HRP20000467B1 - Process for the preparation of simvastatin and derivatives thereof - Google Patents

Process for the preparation of simvastatin and derivatives thereof

Info

Publication number
HRP20000467B1
HRP20000467B1 HR20000467A HRP20000467A HRP20000467B1 HR P20000467 B1 HRP20000467 B1 HR P20000467B1 HR 20000467 A HR20000467 A HR 20000467A HR P20000467 A HRP20000467 A HR P20000467A HR P20000467 B1 HRP20000467 B1 HR P20000467B1
Authority
HR
Croatia
Prior art keywords
formula
protecting group
simvastatin
derivatives
preparation
Prior art date
Application number
HR20000467A
Other languages
English (en)
Croatian (hr)
Inventor
Zupan�i� Silvo
�timac Anton
Gnidovec Jo�e
Original Assignee
Krka
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Krka filed Critical Krka
Publication of HRP20000467A2 publication Critical patent/HRP20000467A2/hr
Publication of HRP20000467B1 publication Critical patent/HRP20000467B1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30Oxygen atoms, e.g. delta-lactones
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyrane Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
HR20000467A 1998-02-26 2000-07-07 Process for the preparation of simvastatin and derivatives thereof HRP20000467B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SI9800057A SI9800057A (sl) 1998-02-26 1998-02-26 Postopek za pripravo simvastatina in njegovih derivatov
PCT/SI1999/000006 WO1999043665A1 (en) 1998-02-26 1999-02-24 Process for the preparation of simvastatin and derivatives thereof

Publications (2)

Publication Number Publication Date
HRP20000467A2 HRP20000467A2 (en) 2001-02-28
HRP20000467B1 true HRP20000467B1 (en) 2009-02-28

Family

ID=20432210

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20000467A HRP20000467B1 (en) 1998-02-26 2000-07-07 Process for the preparation of simvastatin and derivatives thereof

Country Status (18)

Country Link
US (1) US6252091B1 (xx)
EP (1) EP1056737B1 (xx)
AT (1) ATE243207T1 (xx)
AU (1) AU3284699A (xx)
BG (1) BG64826B1 (xx)
CZ (1) CZ297405B6 (xx)
DE (1) DE69908909T2 (xx)
EA (1) EA002370B1 (xx)
EE (1) EE04345B1 (xx)
HR (1) HRP20000467B1 (xx)
HU (1) HU227916B1 (xx)
NO (1) NO326301B1 (xx)
PL (1) PL194713B1 (xx)
RS (1) RS49712B (xx)
SI (1) SI9800057A (xx)
SK (1) SK284137B6 (xx)
UA (1) UA56303C2 (xx)
WO (1) WO1999043665A1 (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI20116A (sl) 1998-12-02 2000-06-30 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Nov postopek za pripravo simvastatina in njegovih analogov
AU1683000A (en) * 1998-12-10 2000-06-26 Kaneka Corporation Process for producing simvastatin
US6573385B1 (en) 1999-11-11 2003-06-03 Biocon India Limited Process for manufacturing simvastatin and novel intermediates thereof
US6573392B1 (en) 1999-11-11 2003-06-03 Biocon India Limited Process for manufacturing simvastatin and the novel intermediates
CN1446088A (zh) 2000-07-27 2003-10-01 普拉斯化学品有限公司 高度纯化的辛伐他汀组合物
US6603022B1 (en) 2002-05-10 2003-08-05 Biocon India Limited Process for manufacturing Simvastatin and novel intermediates thereof
SK285772B6 (sk) * 2002-11-20 2007-08-02 Zentiva, A. S. Spôsob prípravy simvastatínu
CN102070587B (zh) * 2011-01-13 2015-10-14 广东东阳光药业有限公司 一锅法制备辛伐他汀的方法
WO2014168933A1 (en) 2013-04-08 2014-10-16 Cytodyn Inc. Felinized antibodies and methods of treating retroviral infections in felines
CN104311517B (zh) * 2014-10-17 2017-06-06 上海应用技术学院 他汀内酯脱水化合物及其用途
CN104356120B (zh) * 2014-10-17 2017-05-03 上海应用技术学院 多取代喹啉类他汀内酯脱水化合物及其用途
CN105111173B (zh) * 2015-06-26 2017-06-23 上海应用技术学院 他汀含氟衍生物及其用途

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0033538A2 (en) * 1980-02-04 1981-08-12 Merck & Co. Inc. 6(R)-(2-(8'-acyloxy-2'-methyl-6'-methyl (or hydrogen)-polyhydronaphthyl-1')-ethyl)-4(R)-hydroxy-3,4,5,6-tetrahydro-2H-pyran-2-ones, the hydroxy acid form of said pyranones, the pharmaceutically acceptable salts of said hydroxy acids, and the lower alkyl, and phenyl, dimethylamino or acetylamino substituted lower alkyl esters of said hydroxy acid, processes for preparing the same, and a pharmaceutical antihypercholesterolemic composition containing the same
US4444784A (en) * 1980-08-05 1984-04-24 Merck & Co., Inc. Antihypercholesterolemic compounds
EP0287340A2 (en) * 1987-04-15 1988-10-19 Merck & Co. Inc. Novel acylation process for the synthesis of HMG-COA reductase inhibitors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR69216B (xx) 1979-06-15 1982-05-07 Merck & Co Inc
DE3480923D1 (de) * 1983-10-11 1990-02-08 Merck & Co Inc Verfahren zur c-methylierung von 2-methylbutyraten.
US4820850A (en) * 1987-07-10 1989-04-11 Merck & Co., Inc. Process for α-C-alkylation of the 8-acyl group on mevinolin and analogs thereof
CA2036962C (en) 1990-02-26 1998-09-15 Ann E. Decamp Process for the desilylation of a 4-silyloxy-tetrahydro-pyran-2-one
US5223415A (en) * 1990-10-15 1993-06-29 Merck & Co., Inc. Biosynthetic production of 7-[1',2',6',7',8',8a'(R)-hexahydro-2'(S),6'(R)-dimethyl-8'(S)-hydroxy-1'(S)-naphthyl]-3(R),5(R)-dihydroxyheptanoic acid (triol acid)
SI9500238A (en) 1995-07-27 1997-02-28 Krka Tovarna Zdravil Procedure for the production of lovastatin

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0033538A2 (en) * 1980-02-04 1981-08-12 Merck & Co. Inc. 6(R)-(2-(8'-acyloxy-2'-methyl-6'-methyl (or hydrogen)-polyhydronaphthyl-1')-ethyl)-4(R)-hydroxy-3,4,5,6-tetrahydro-2H-pyran-2-ones, the hydroxy acid form of said pyranones, the pharmaceutically acceptable salts of said hydroxy acids, and the lower alkyl, and phenyl, dimethylamino or acetylamino substituted lower alkyl esters of said hydroxy acid, processes for preparing the same, and a pharmaceutical antihypercholesterolemic composition containing the same
US4444784A (en) * 1980-08-05 1984-04-24 Merck & Co., Inc. Antihypercholesterolemic compounds
EP0287340A2 (en) * 1987-04-15 1988-10-19 Merck & Co. Inc. Novel acylation process for the synthesis of HMG-COA reductase inhibitors

Also Published As

Publication number Publication date
NO20004221D0 (no) 2000-08-23
SI9800057A (sl) 1999-08-31
AU3284699A (en) 1999-09-15
RS49712B (sr) 2007-12-31
CZ297405B6 (cs) 2006-12-13
EA200000881A1 (ru) 2001-02-26
UA56303C2 (uk) 2003-05-15
SK284137B6 (sk) 2004-09-08
DE69908909D1 (de) 2003-07-24
PL342511A1 (en) 2001-06-18
US6252091B1 (en) 2001-06-26
HRP20000467A2 (en) 2001-02-28
HUP0100743A2 (hu) 2001-11-28
SK12582000A3 (sk) 2002-01-07
EP1056737B1 (en) 2003-06-18
DE69908909T2 (de) 2003-12-04
NO20004221L (no) 2000-08-23
BG64826B1 (bg) 2006-05-31
WO1999043665A1 (en) 1999-09-02
EA002370B1 (ru) 2002-04-25
HUP0100743A3 (en) 2002-04-29
HU227916B1 (en) 2012-06-28
YU46600A (sh) 2003-12-31
PL194713B1 (pl) 2007-06-29
CZ20002857A3 (cs) 2000-11-15
BG104749A (en) 2001-04-30
ATE243207T1 (de) 2003-07-15
EE04345B1 (et) 2004-08-16
EP1056737A1 (en) 2000-12-06
EE200000479A (et) 2002-02-15
NO326301B1 (no) 2008-11-03

Similar Documents

Publication Publication Date Title
HRP20000467B1 (en) Process for the preparation of simvastatin and derivatives thereof
RU95104885A (ru) 1h-индол-3-глиоксиламиды, ингибирующие spla2-медируемое выделение жирных кислот, фармацевтическая композиция
TR200000065T2 (tr) Epotilon türevleri.
BR9914814A (pt) Processo para a preparação de luteolina e derivados de luteolina
IS1806B (is) Arylthíósambönd sem varnarefni gegn bakteríum og veirum
ES2140961T3 (es) Nuevos derivados de 19-nor-pregneno.
GB2303851A (en) Pharmaceutical diketopiperazine compounds
TR199802255T2 (xx) Eklembacakl�lar� uzakla�t�ran maddeler.
CA2266759A1 (en) 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase
GB9810659D0 (en) Organic compounds
DE69623555D1 (de) Inhibitor der krebsmetastasierung
FR2677023B1 (fr) Derives de coumarine hydrosolubles, leur preparation et leur utilisation comme substrat d'enzyme.
WO1999033825A8 (en) N-phenylamide and n-pyridylamide derivatives, method of preparing them and pharmaceutical compositons containing them
DK0668279T3 (da) 6-azaindol thromboxansytaseinhibitor
FI954138A (fi) Hydroksimetyylifuratsaanikarboksyylihappojohdannaiset ja niiden käyttö sydänverisuonitautien käsittelyssä
IL145869A0 (en) A process for the production of paclitaxel and novel paclitaxel derivatives
TR199801232T2 (xx) Bakatin t�revlerini se�i�i olarak koruma y�ntemi
DE60002486D1 (de) 1,4-dihydropyridin-5-carbonsäureester-derivate und verfahren zu ihrer herstellung
DE69907671D1 (en) Hydroxyphenylsulfanylbenzoesäure- und -arylessigsäure-derivate
ATE189886T1 (de) Synthese von carbonsäurederivaten
HUP9904624A2 (hu) Szacharinszármazékok, eljárás előállításukra, az ezeket tartalmazó gyógyszerkészítmények és intermedierjeik
PT777471E (pt) Metodo de inibicao da biosintese de leucotrieno
TH9340A (th) อนุพันธ์ของวิตามินอี ชนิดใหม่ของกรรมวิธีสำหรับการผลิตสารนั้น
TH34999A (xx)
TH9340EX (th) อนุพันธ์ของวิตามินอี ชนิดใหม่ของกรรมวิธีสำหรับการผลิตสารนั้น

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20130213

Year of fee payment: 15

PBON Lapse due to non-payment of renewal fee

Effective date: 20140224